Effects of Acute Maximum-Intensity Exercise on Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 Levels in Adult Males with Type 1 Diabetes Mellitus Treated with Insulin Pumps
- PMID: 39685536
- PMCID: PMC11641960
- DOI: 10.3390/jcm13237077
Effects of Acute Maximum-Intensity Exercise on Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 Levels in Adult Males with Type 1 Diabetes Mellitus Treated with Insulin Pumps
Abstract
Background: Dysregulation of matrix metalloproteinases (MMPs) activity is considered one of the potential causes of vascular complications in diabetic patients. Since training volume may influence MMPs levels in varying ways, the aim of our study was to evaluate changes in MMPs levels following acute maximum-intensity exercise in male patients with type 1 diabetes mellitus (T1DM). Methods: This study included 24 male T1DM patients and 10 healthy controls. Aerobic capacity was evaluated with a treadmill test. Levels of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and tissue inhibitor of metalloproteinase-1 (TIMP-1) were measured both before the aerobic capacity test and 60 min after its completion utilizing enzyme-linked immunosorbent assay (ELISA) system kits. Results: Before the aerobic capacity test only, MMP-9 serum levels were significantly elevated in the T1DM group compared to the controls. Following maximum-intensity exercise, the levels of MMP-2, MMP-9, and TIMP-1 were significantly higher in T1DM patients than in the control group. Between-group comparisons revealed that maximum-intensity exercise induced a statistically significant increase in MMP-2 serum levels from baseline in T1DM patients compared to controls. Conclusions: Our findings suggest that high-intensity exercise in T1DM patients leads to dysregulation of MMPs, as manifested by a significant increase in MMP-2 levels. This dysregulation may play a role in the development of vascular complications in diabetic patients.
Keywords: T1DM; diabetes mellitus; metalloproteinases; physical activity.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.Thromb Res. 2005;115(3):205-10. doi: 10.1016/j.thromres.2004.08.023. Thromb Res. 2005. PMID: 15617743
-
Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes.Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):741-9. doi: 10.1007/s00417-012-2221-3. Epub 2012 Dec 20. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23254483
-
Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus.Mt Sinai J Med. 2006 Nov;73(7):1024-8. Mt Sinai J Med. 2006. PMID: 17195891
-
Plasma Levels of MMPs and TIMP-1 in Patients with Osteoarthritis After Recovery from COVID-19.Rev Recent Clin Trials. 2023;18(2):123-128. doi: 10.2174/1574887118666230131141608. Rev Recent Clin Trials. 2023. PMID: 37231778
-
Matrix metalloproteinases in exercise and obesity.Vasc Health Risk Manag. 2016 Jul 14;12:287-95. doi: 10.2147/VHRM.S103877. eCollection 2016. Vasc Health Risk Manag. 2016. PMID: 27471391 Free PMC article. Review.
References
-
- Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., Raleigh V.S., Lawrenson R.A., Colhoun H.M. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: A cohort study using the general practice research database. Diabetes Care. 2006;29:798–804. doi: 10.2337/diacare.29.04.06.dc05-1433. - DOI - PubMed
-
- Miller R.G., Mahajan H.D., Costacou T., Sekikawa A., Anderson S.J., Orchard T.J. A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults with Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2016;39:2296–2303. doi: 10.2337/dc16-1162. - DOI - PMC - PubMed
-
- Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., Raleigh V.S., Lawrenson R.A., Colhoun H.M. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia. 2006;49:660–666. doi: 10.1007/s00125-005-0120-4. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous